Lung carcinoma

Related records

Broader conditions (19)

• Cancer
• Cancer or benign tumor
• Carcinoma
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Epithelial neoplasm
• Human disease
• Lower respiratory tract disorder
• Lung cancer
• Lung disorder
• Lung neoplasm
• Neoplasm
• Neoplasm of thorax
• Neoplastic disease or syndrome
• Respiratory system cancer
• Respiratory system disorder
• Respiratory tract neoplasm
• Thoracic cancer

Narrower conditions (52)

• Acinar lung adenocarcinoma
• Adenosquamous lung carcinoma
• Asbestos-related lung carcinoma
• Basaloid large cell lung carcinoma
• Bronchogenic carcinoma
• Bronchus carcinoma in situ
• Bronchus mucoepidermoid carcinoma
• Classic pulmonary blastoma
• Combined lung carcinoma
• Combined small cell lung carcinoma
• Epithelial predominant pulmonary blastoma
• Fetal lung interstitial tumor
• Large cell carcinoma with rhabdoid phenotype
• Large cell lung carcinoma, clear cell variant
• Lung adenocarcinoma
• Lung adenocarcinoma in situ
• Lung adenoid cystic carcinoma
• Lung carcinoma in situ
• Lung colloid adenocarcinoma
• Lung combined large cell neuroendocrine carcinoma

Trials (157)

• 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
• 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
• 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
• A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer
• A Biomarker Screening Protocol for Participants With Solid Tumors
• A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
• A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
• A Nurse-Led Intervention for Fear of Progression in Advanced Cancer
• A Phase I Study of iPS Cell Generation From Patients With COPD
• A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer
• A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
• A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
• A Study of SKB518 in Patients With Lung Cancer
• A Study to Investigate LYL797 in Adults With Solid Tumors
• A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
• A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle
• A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
• An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
• An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Drugs in development (26)

• Arsenic trioxide Phase 2
• Camrelizumab Phase 2
• Canakinumab Phase 3
• Catequentinib Phase 3
• Cisplatin Phase 3
• Dexamethasone Phase 2
• Docetaxel Phase 3
• Durvalumab Phase 3
• Everolimus Phase 2
• Famitinib Phase 2
• Ferumoxytol Phase 2
• Gefitinib Phase 3
• Hiltonol Phase 1
• Iloprost Phase 2
• Irinotecan hydrochloride Phase 3
• Metformin hydrochloride Phase 2
• Pasireotide Phase 2
• Pembrolizumab Phase 3
• Porfimer sodium Phase 2
• Ramucirumab Phase 2

Other linked drugs (1)

• Nicotine